Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Malignant Lymphoma

  Free Subscription


1 Am J Hematol
1 Blood
1 BMC Cancer
3 Bone Marrow Transplant
1 Br J Cancer
1 Br J Dermatol
3 Br J Haematol
2 Haematologica
1 Hum Pathol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Hematol

  1. FLINN IW, Cherry MA, Maris MB, Matous JV, et al
    Combination Trial of Duvelisib (IPI-145) with Rituximab or Bendamustine/Rituximab in Patients with Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia.
    Am J Hematol. 2019 Sep 6. doi: 10.1002/ajh.25634.
    PubMed     Text format     Abstract available


  2. ALI ND, Bains A
    Triple hit B-cell lymphoma with diffuse kidney involvement sparing the glomeruli.
    Blood. 2019;134:842.
    PubMed     Text format    

    BMC Cancer

  3. LIN JL, Lin JX, Li P, Xie JW, et al
    Dynamic prediction of long-term survival in patients with primary gastric diffuse large B-cell lymphoma: a SEER population-based study.
    BMC Cancer. 2019;19:873.
    PubMed     Text format     Abstract available

    Bone Marrow Transplant

  4. HERR MM, Torka P, Zhang Y, Wallace PK, et al
    Correction: Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant.
    Bone Marrow Transplant. 2019 Aug 30. pii: 10.1038/s41409-019-0647.
    PubMed     Text format     Abstract available

  5. HILL BT, Roberts ZJ, Xue A, Rossi JM, et al
    Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma.
    Bone Marrow Transplant. 2019 Aug 30. pii: 10.1038/s41409-019-0657.
    PubMed     Text format    

  6. BROWNBACK KR, Pitts LR, Abhyankar S
    Safety of nintedanib for treatment of fibrotic lung disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 26. pii: 10.1038/s41409-018-0182.
    PubMed     Text format    

    Br J Cancer

  7. MAGNI M, Biancon G, Rizzitano S, Cavane A, et al
    Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma.
    Br J Cancer. 2019 Sep 2. pii: 10.1038/s41416-019-0557.
    PubMed     Text format     Abstract available

    Br J Dermatol

    Health-related quality of life in cutaneous T-cell lymphoma: examining all sides of the issue.
    Br J Dermatol. 2019 Sep 2. doi: 10.1111/bjd.18428.
    PubMed     Text format    

    Br J Haematol

    Epigenetic targeting in mantle cell lymphoma.
    Br J Haematol. 2019;186:805-806.
    PubMed     Text format    

  10. PEDERSEN MA, Gormsen LC, d'Amore F
    Value of detecting bone marrow involvement in Hodgkin lymphoma - Response to Adams and Kwee.
    Br J Haematol. 2019 Sep 4. doi: 10.1111/bjh.16180.
    PubMed     Text format    

  11. KANATE AS, Savani BN
    Who is the best relative - optimizing haploidentical donor transplantation in lymphoma?
    Br J Haematol. 2019 Sep 2. doi: 10.1111/bjh.16178.
    PubMed     Text format    


  12. DRIEUX F, Ruminy P, Abdel-Sater A, Lemonnier F, et al
    Defining the signatures of peripheral T-cell lymphoma, with a targeted 20-markers gene expression profiling assay (RT-MLPA).
    Haematologica. 2019 Sep 5. pii: haematol.2019.226647.
    PubMed     Text format     Abstract available

  13. EYRE TA, Djebbari F, Kirkwood AA, Collins GP, et al
    A systematic review of the efficacy of CNS prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era.
    Haematologica. 2019 Sep 5. pii: haematol.2019.229948.
    PubMed     Text format     Abstract available

    Hum Pathol

  14. SWERDLOW SH, Cook JR
    As the world turns, evolving lymphoma classifications - past, present and future.
    Hum Pathol. 2019 Sep 4. pii: S0046-8177(19)30159.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.